ARCHIVES

Advocacy Group Urges FDA to Sift Through Avastin Glioblastoma Data—Agency Accepts

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

FDA carries Action On Two Cancer Drugs Over To 1996

January 5, 1996

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

Guidelines Adopted For Pathology Review

February 22, 1980

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004

NCI-Approved Clinical Trials

January 27, 2006